From 2020, Korean Animal and Plant Quarantine Agency has reset the withdrawal time (WT) for veterinary drugs typically used in livestock in preparation for the introduction of positive list system (PLS) program in 2024. This study was conducted to reset the MRL for tiamulin (TML) in broiler chickens as a part of PLS program introduction. Forty-eight healthy Ross broiler chickens were orally administered with TML at the concentration of 25 g/L (TML-1, n=24) and 50 g/L (TML-2, n=24) for 5 days through drinking water, respectively. After the drug treatment, tissue samples were collected from six broiler chickens at 1, 2, 3 and 5 days, respectively. According to the previously established analysis method, residual TML concentrations in poultry tissues were determined using LC-MS/MS. In TML-1, TML in all tissues was detected less than LOQ at 2 days after drug treatment. In TML-2, TML in liver and kidney was detected more than LOQ at 2 days after treatment. According to the European Medicines Agency’s guideline on determination of withdrawal periods, withdrawal periods of TML-1 and TML-2 in poultry tissues were established to 0 and 2 days, respectively. In conclusion, the estimated WT of TML in poultry tissues is shorter than the current WT recommendation of 5 days for TML in broiler chickens.

This study was investigated the synergistic antibacterial effects from the combination of sulfamethazine (SMZ) and tiamulin (SMT) against Salmonella Typhimurium (S. Typhimurium) and Actinobacillus pleuropneumoniae (A. pleuropneumoniae) isolated from pigs. Minimum inhibitory concentrations (MICs) and fractional inhibitory concentration (FIC) index were determined for 10 bacteria from 13 swine farms in Gyeongsangnam province by the National Committee for Clinical Laboratory Standards broth microdilution procedure. Antimicrobial agents tested included SMZ, tiamulin and SMT. Against S. Typhimurium and A. pleuropneumoniae, the MIC ranges of SMZ, tiamulin and SMT were 125-500, 15.625-62.5 and 15.625-62.5 μg/mL, respectively. In addition, the FIC index ranges of SMT against S. Typhimurium and A. pleuropneumoniae were 0.19-0.38 and 0.19-0.62, respectively. In conclusion, SMT has a high antibacterial activity against S. Typhimurium and A. pleuropneumoniae, then the combination may be applied for the treatment of swine diseases caused by S. Typhimurium and A. pleuropneumoniae.

수산 양식 산업에서 발생하는 다제내성균에 의한 질병을 통제하기 위해 기존에 사용하던 수산 용 의약품 대신 어류에 사용이 금지된 동물용 의약품 사용이 증가하고 있다. 그 중, 티아물린 은 그람 양성균에 효과적인 항균성을 나타내기 때문에 일부 양식 어가에서 불법적으로 사용 되고 있다. 불법적 사용을 막기 위해서는 티아물린의 수산동물에 대한 연구를 통해 수의사나 수산질병관리사의 처방전에 따라 수산생물의 치료행위가 수반되어야 한다. 연쇄구균에 감염된 강도다리에 대해 티아물린을 5, 10, 15 mg kg-1의 농도로 근육주사 하였으나 치료 효과가 나타 나지 않았고 15, 30 mg kg-1의 농도로 경구투여 하였으나 마찬가지로 치료 효과가 미비하였다. 안전성 확인을 위해 30, 60 mg kg-1의 농도로 근육주사와 경구투여한 경우 항생제의 독성에 의한 폐사가 발생하였고 따라서 연쇄구균에 감염된 강도다리에 티아물린으로 항생제 처리를 하는 것은 부적절하다고 할 수 있다.